|
CMS initiates this national coverage analysis of the current non-covered indications. The initial 30-day public comment period begins with this posting date, and ends after 30 calendar days.
CMS is requesting public comment on the health benefit outcomes of any of the current non-covered indications of Magnetic Resonance Angiography (MRA) in the Medicare population.
CMS considers all public comments, and is particularly interested in comments regarding clinical studies and other scientific information about the technology under review and the short and long term outcomes.
Instructions on submitting public comments can be found at http://www.cms.hhs.gov/InfoExchange/02_publiccomments.asp. You can also submit a public comment by clicking on the highlighted word COMMENT in the title bar at the top of this page. We strongly urge that all public comments be submitted through this website. Please do not submit personal health information in public comments. Comments with personal health information may not be posted to the website.
|